Effectdossier · gearchiveerd kwartaal
RIGL
Rigel Pharmaceuticals, Inc. · Healthcare · Biotechnology
18Gevolgde houders
+3Δ houders
6.87MGehouden aandelen
$194.53MGerapporteerde waarde
+3Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +20.0% ·
aandelenstroom +26.6% ·
netto nieuwe posities +16.7%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | -2 | 9.47M | $370.29M | +3 | −5 |
| Q1 2026 | 77 | -10 | 11.13M | $301.00M | — | −10 |
| Q4 2025 | 86 | +1 | 11.49M | $491.92M | +1 | — |
| Q3 2025 | 18 | +3 | 6.87M | $194.53M | +3 | — |
| Q2 2025 | 12 | +2 | 4.47M | $83.70M | +2 | — |
| Q1 2025 | 7 | -1 | 1.55M | $27.81M | +2 | −3 |
| Q4 2024 | 8 | +4 | 1.41M | $23.66M | +5 | −1 |
| Q3 2024 | 3 | -2 | 554.02K | $8.97M | — | −2 |
| Q2 2024 | 5 | — | 605.71K | $4.98M | — | — |
Wie het bezit · Q3 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 1.72M | +6.1% | $48.87M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (passief) | 1.04M | -0.9% | $29.55M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passief) | 1.04M | -0.9% | $29.55M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passief) | 1.04M | -0.9% | $29.55M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Goldman Sachs Group ✦ | 737.03K | — | $20.88M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Goldman Sachs Group ✦ | 737.03K | — | $20.88M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 601.33K | +63.0% | $17.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 601.33K | +63.0% | $17.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (passief) | 554.32K | -7.6% | $15.70M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 474.21K | +100.6% | $13.43M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passief) | 423.72K | +1.9% | $12.01M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passief) | 423.72K | +1.9% | $12.01M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 306.49K | Nieuw | $8.68M | 0.0% | New | 1 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 306.49K | Nieuw | $8.68M | 0.0% | New | 1 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 220.30K | +474.6% | $6.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | Arrowstreet Capital ✦ | 186.33K | +747.6% | $5.28M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 146.27K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 146.27K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 146.27K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 146.27K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 146.27K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 146.27K | — | $4.14M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Millennium Management ✦ | 105.30K | +236.9% | $2.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 86.46K | Nieuw | $2.45M | 0.0% | New | 1 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 86.46K | Nieuw | $2.45M | 0.0% | New | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 69.92K | — | $1.98M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 69.92K | — | $1.98M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 69.92K | — | $1.98M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 69.92K | — | $1.98M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 69.92K | — | $1.98M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 69.92K | — | $1.98M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Wellington Management ✦ | 61.77K | -3.2% | $1.75M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 42 | Wellington Management ✦ | 61.77K | -3.2% | $1.75M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 43 | Wellington Management ✦ | 61.77K | -3.2% | $1.75M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 44 | Fidelity (FMR) ✦ | 59.09K | +1641.4% | $1.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 59.09K | +1641.4% | $1.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 59.09K | +1641.4% | $1.67M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 56.60K | +463.9% | $1.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 56.60K | +463.9% | $1.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 49 | AQR Capital Management ✦ | 56.60K | +463.9% | $1.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 50 | AQR Capital Management ✦ | 56.60K | +463.9% | $1.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 56.60K | +463.9% | $1.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 52 | T. Rowe Price ✦ | 9.29K | Nieuw | $264,000 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| D. E. Shaw & Co. | $8.68M | 0.0% |
| D. E. Shaw & Co. | $8.68M | 0.0% |
| Citadel Advisors | $2.45M | 0.0% |
| Citadel Advisors | $2.45M | 0.0% |
| T. Rowe Price | $264,000 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 146 houders, 15.81M aandelen, $391.97M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q3 2025 ·
Methodologie ·
Verkrijg dit via de API